Authors' objectives: This Technology note follows from a referral to the National Health Committee (NHC) proposing a pilot study of Abbott Laboratory's MitraClip® procedure at Waikato DHB. The MitraClip® procedure is a percutaneous intervention for mitral valve repair to treat mitral regurgitation (MR). As new health technologies often face competing technologies, alternative percutaneous interventions for the repair or replacement of the mitral valve have been reviewed. The evidence base for the emerging procedures is still fairly limited with only MitraClip® having a published randomised controlled trial to its name. Furthermore, although many such interventions are in development, only two are currently available on the market internationally; these are MitraClip® and Cardiac Dimension's Carillon® procedure. Accordingly, the paper is largely focused on MitraClip® as it has the most developed evidence base. The paper summarises available evidence on the population burden of disease for MR, and evaluates the safety, efficacy, effectiveness and cost-effectiveness evidence for percutaneous interventions.

Project Status: Completed

Year Published: 2013

URL for published report: http://nhc.health.govt.nz/committee-publications/percutaneous-interventions-mitral-regurgitation-technology-note

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: New Zealand

Organisation Name: New Zealand National Health Committee

Contact Address: National Health Committee, PO Box 5013, 6145 Wellington New ZealandTel: +64 4 496 2120

Contact Name: nhc_info@nhc.govt.nz

Contact Email: nhc_info@nhc.govt.nz

Copyright: New Zealand National Health Committee (NHC)